The following discussion of our consolidated results of operations and cash flows for the three and nine months ended September 30, 2020 and 2019, and consolidated financial conditions as of September 30, 2020 and December 31, 2019 should be read in conjunction with our unaudited consolidated financial statements and the related notes included elsewhere in this document.





Overview



We are a major grower and seller of yew trees and manufacturer of products made
from yew trees, we also sell branches and leaves of yew trees for the
manufacture of TCM containing taxol, which TCM has been approved in the PRC for
use as a secondary treatment of certain cancers, meaning it must be administered
in combination with other pharmaceutical drugs. The yew industry is highly
regulated in the PRC because the northeast yew tree is considered an endangered
species. In the third quarter of 2016, we started to sell handmade yew essence
oil soaps and candles.



We operated in two reportable business segments. The business of HDS, JSJ, HYF
and JCB in PRC was managed and reviewed as PRC segment. The business of YBP, Yew
Bio-Pharm (HK), and MC was managed and reviewed as USA segment.



For the three months ended September 30, 2020 and 2019, revenues from the PRC
segment accounted for approximately 99.82% and 87.02% of consolidated revenue,
respectively; revenues from USA segment accounted for approximately 0.18% and
12.980% of consolidated revenue, respectively.



For the nine months ended September 30, 2020 and 2019, revenues from the PRC
segment accounted for approximately 99.84% and 99.17% of consolidated revenue,
respectively; revenues from USA segment accounted for approximately 0.16% and
0.83% of consolidated revenue, respectively.



The Company's revenues were mostly generated by HDS in the PRC. The expenses
incurred in the U.S. were primarily related to fulfilling the reporting
requirements of public listed company, stock-based compensation, office daily
operations and other costs. As of September 30, 2020, the Company had $1,224,293
in cash and held the 100% equity interests in its subsidiaries Yew HK and JSJ.
Yew HK itself has no business operations or assets other than holding of equity
interests in JSJ. JSJ has no business operations and assets with a book value of
approximately $6,000, including approximately $4,000 in cash on September 30,
2020. JSJ also holds the VIE interests in HDS through the contractual
arrangements (the "Contractual Arrangements") described in Notes to Consolidated
Financial Statements. On November 2014 and March 2020, HDS established new
subsidiaries, HYF, to develop and cultivate wood ear mushroom drink, and JCB, to
sales of yew oil products. As of September 30, 2020, HYF had started pilot
production with limited amount of sales. In the event that we are unable to
enforce the Contractual Agreements, we may not be able to exert effective
control over HDS and HYF, and our ability to conduct our business may be
materially and adversely affected. If the applicable PRC authorities invalidate
our Contractual Agreements for any violation of PRC laws, rules and regulations,
we would lose control of the VIE and its subsidiary resulting in its
deconsolidation in financial reporting and severe loss in our market valuation.
On June 8, 2016, YBP established a new subsidiary, MC, to sales the Company's
yew products in American market. MC had limited operation activities for the
nine months ended September 30, 2020.



In December 2019, COVID-19 was reported in China. Since then, COVID-19 has
spread globally, to include the United States and several European countries.
Many countries around the world have imposed quarantines and restrictions on
travel and mass gatherings to slow the spread of the virus and have closed
non-essential businesses. The pandemics could result in increased travel
restrictions, market downturns and changes in the behavior of the terminal
customers of our products related to pandemic fears. In addition, our certain
customers could decrease the demand on our products due to the outbreak of the
COVID-19. To date, our business is impact by the outbreak of the coronavirus
(COVID-19) in China, which resulted the decrease of our revenue during the first
half of 2020. The extent to which the coronavirus impacts our results will
depend on future developments and reactions in China, which are highly uncertain
and will include emerging information concerning the severity of the coronavirus
and the actions taken by governments to attempt to contain the coronavirus. Any
decreased collectability of accounts receivable, or reduction of purchase orders
could further negatively impact our results of operations.



Critical accounting policies and estimates





Our discussion and analysis of our financial condition and results of operations
are based upon our consolidated financial statements, which have been prepared
in accordance with accounting principles generally accepted in the United
States. The preparation of these consolidated financial statements requires us
to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets
and liabilities. We continually evaluate our estimates, including those related
to bad debts, allowance for obsolete inventory, and the classification of short
and long-term inventory, the useful life of property and equipment and
intangible assets, recovery of long-lived assets, income taxes, write-down in
value of inventory, and the valuation of equity transactions. We base our
estimates on historical experience and on various other assumptions that we
believed to be reasonable under the circumstances, the results of which form the
basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. Any future changes to these
estimates and assumptions could cause a material change to our reported amounts
of revenues, expenses, assets and liabilities. Actual results may differ from
these estimates under different assumptions or conditions. We believe the
following critical accounting policies affect our significant judgments and
estimates used in the preparation of the financial statements.



25






Variable interest entities



Pursuant to ASC 810 and related subtopics related to the consolidation of
variable interest entities, we are required to include in our consolidated
financial statements the financial statements of VIEs. The accounting standards
require a VIE to be consolidated by a company if that company is subject to the
risk of loss for the VIE or is entitled to receive the VIE's residual returns.
VIEs are those entities in which we, through contractual arrangements, bear the
risk of, and enjoy the rewards normally associated with ownership of the entity,
and therefore we are the primary beneficiary of the entity. HDS is considered a
VIE, and we are the primary beneficiary. We entered into agreements with HDS
pursuant to which we shall receive 100% of HDS's net income. In accordance with
these agreements, HDS shall pay consulting fees equal to 100% of its net income
to our wholly owned subsidiary, JSJ. JSJ shall supply the technology and
administrative services needed to service the HDS.



The accounts of HDS are consolidated in the accompanying financial statements.
As a VIE, HDS' sales are included in our total sales, its income from operations
is consolidated with ours, and our net income includes all of HDS' net income,
and their assets and liabilities are included in our consolidated balance
sheets. The VIEs do not have any non-controlling interest and, accordingly, we
did not subtract any net income in calculating the net income attributable to
us. Because of the contractual arrangements, we have pecuniary interest in HDS
that requires consolidation of HDS' financial statements with our financial
statements.



As required by ASC 810-10, we perform a qualitative assessment to determine
whether we are the primary beneficiary of HDS which is identified as a VIE of
us. A quality assessment begins with an understanding of the nature of the risks
in the entity as well as the nature of the entity's activities including terms
of the contracts entered into by the entity, ownership interests issued by the
entity and the parties involved in the design of the entity. The significant
terms of the agreements between us and HDS are discussed above in the "Corporate
Structure and Recapitalization - Second Restructure" section. Our assessment on
the involvement with HDS reveals that we have the absolute power to direct the
most significant activities that impact the economic performance of HDS. JSJ,
our wholly own subsidiary, is obligated to absorb a majority of the risk of loss
from HDS activities and is entitled to receive a majority of HDS's expected
residual returns. In addition, HDS' shareholders have pledged their equity
interest in HDS to JSJ, irrevocably granted JSJ an exclusive option to purchase,
to the extent permitted under PRC Law, all or part of the equity interests in
HDS and agreed to entrust all the rights to exercise their voting power to the
person(s) appointed by JSJ. Under the accounting guidance, we are deemed to be
the primary beneficiary of HDS and the results of HDS' operation are
consolidated in our consolidated financial statements for financial reporting
purposes.



Accordingly, as a VIE, HDS' sales are included in our total sales, its income
from operations is consolidated with our income from operations and our net
income includes all of HDS' net income. All the equity (net assets) and profits
(losses) of HDS are attributed to us. Therefore, no non-controlling interest in
HDS is presented in our consolidated financial statements. As we do not have any
non-controlling interest and, accordingly, did not subtract any net income in
calculating the net income attributable to us. Because of the Contractual
Arrangements, YBP has a pecuniary interest in HDS that requires consolidation of
HDS' financial statements with those of ours.



Additionally, pursuant to ASC 805, as YBP and HDS are under the common control
of the HDS Shareholders, the Second Restructure was accounted for in a manner
similar to a pooling of interests. As a result, our historical amounts in the
accompanying consolidated financial statements give retrospective effect to the
Second Restructure, whereby our assets and liabilities are reflected at the
historical carrying values and their operations are presented as if they were
consolidated for all periods presented, with our results of operations being
consolidated from the date of the Second Transfer Agreement. The accounts of HDS
are consolidated in the accompanying financial statements.



Accounts receivable



Accounts receivable are presented net of an allowance for doubtful accounts. We
maintain allowances for doubtful accounts for estimated losses. We review the
accounts receivable balance on a periodic basis and make general and specific
allowances when there is doubt as to the collectability of individual balances.
In evaluating the collectability of individual receivable balances, we consider
many factors, including the age of the balance, a customer's historical payment
history, its current credit-worthiness and current economic trends. Accounts are
written off after exhaustive efforts at collection. We recognize the probability
of the collection for each customer.



Inventories



Inventories consisted of raw materials, work-in-progress, finished
goods-handicrafts, yew seedlings, yew candles and other trees (consisting of
larix, spruce and poplar trees). We classify our inventories based on our
historical and anticipated levels of sales; any inventory in excess of its
normal operating cycle of one year is classified as long-term on our
consolidated balance sheets. Inventories are stated at the lower of cost or
market value utilizing the weighted average method. Raw materials primarily
include yew timber used in the production of products such as handicrafts,
furniture and other products containing yew timber. Finished goods-handicraft
and yew seedlings include direct materials and direct labor.



26






We estimate the amount of the excess inventories by comparing inventory on hand
with the estimated sales that can be sold within our normal operating cycle of
one year. Any inventory in excess of our current requirements based on
historical and anticipated levels of sales is classified as long-term on our
consolidated balance sheets. Our classification of long-term inventory requires
us to estimate the portion of inventory that can be realized over the next

12
months.



To estimate the amount of slow-moving or obsolete inventories, we analyze
movement of our products, monitor competing products and technologies and
evaluate acceptance of our products. Periodically, we identify inventories that
cannot be sold at all or can only be sold at deeply discounted prices. An
allowance will be established if management determines that certain inventories
may not be saleable. If inventory costs exceed expected market value due to
obsolescence or quantities in excess of expected demand, we will record reserves
for the difference between the carrying cost and the estimated market value.



Our handicraft and yew furniture products are hand-made by traditional Chinese artisans.





In accordance with ASC 905, "Agriculture", our costs of growing yew seedlings
are accumulated until the time of harvest and are reported at the lower of

cost
or market.



Property and equipment



Property and equipment are carried at cost and are depreciated on a
straight-line basis (after taking into account their respective estimated
residual value) over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and
improvements are capitalized. When assets are retired or disposed of, the cost
and accumulated depreciation are removed from the accounts, and any resulting
gains or losses are included in income in the year of disposition. We examine
the possibility of decreases in the value of fixed assets when events or changes
in circumstances reflect the fact that their recorded value may not be
recoverable. The estimated useful lives are as follows:



Building                    10 - 20 years
Machinery and equipment      3 - 10 years
Office equipment              2 - 5 years
Motor vehicles               4 - 10 years



Land use rights and yew forest assets





All land in the PRC is owned by the PRC government and cannot be sold to any
individual or company. We have recorded the amounts paid to the PRC government
to acquire long-term interests to utilize land and yew forests as land use
rights and yew forest assets. This type of arrangement is common for the use of
land in the PRC. Yew trees on land containing yew tree forests are used to
supply raw materials such as branches, leaves and fruit to us that will be used
to manufacture our products. We amortize these land and yew forest use rights
over the term of the respective land and yew forest use right, which ranges from
15 to 50 years. The lease agreements do not have any renewal option and we have
no further obligations to the lessor. We record the amortization of these land
and forest use rights as part of our cost of revenues.



Revenue recognition



We generate our revenue from sales of yew seedling products, sales of yew raw
materials for medical application, sales of yew handicraft products, sales of
"Others" including yew candles, yew essential oil soap, pine needle extract,
complex taxus cuspidate extract, and composite northeast yew extract. Pursuant
to the guidance of ASC 606, we recognize revenue when obligations under the
terms of a contract with customer are satisfied; generally, this occurs with the
transfer of control of the products sold. Transfer of control to the customer is
based on the standardized shipping terms in the contract as this determines when
we have the right to payment, the customer has legal title to the asset and the
customer has the risks of ownership.



Income taxes



We are governed by the Income Tax Law of the PRC, Hong Kong and the United
States. We account for income tax using the liability method prescribed by ASC
740, "Income Taxes". Under this method, deferred tax assets and liabilities are
determined based on the difference between the financial reporting and tax bases
of assets and liabilities using enacted tax rates that will be in effect in the
year in which the differences are expected to reverse. We record a valuation
allowance to offset deferred tax assets if based on the weight of available
evidence; it is more-likely-than-not that some portion, or all, of the deferred
tax assets will not be realized. The effect on deferred taxes of a change in tax
rates is recognized as income or loss in the period that includes the enactment
date.



We apply the provisions of ASC 740-10-50, "Accounting for Uncertainty in Income
Taxes", which provides clarification related to the process associated with
accounting for uncertain tax positions recognized in our financial statements.
Audit periods remain open for review until the statute of limitations has
passed. The completion of review or the expiration of the statute of limitations
for a given audit period could result in an adjustment to our liability for
income taxes. Any such adjustment could be material to our results of operations
for any given quarterly or annual period based, in part, upon the results of
operations for the given period. Currently, we have no uncertain tax positions,
and will continue to evaluate for uncertain positions in the future.



27






Stock-based compensation



The Company accounts for equity-based compensation cost in accordance with ASC
718, Compensation-Stock Compensation after adoption of ASC 2018-07, which
requires the measurement and recognition of compensation expense related to the
fair value of equity-based compensation awards that are ultimately expected to
vest. Stock-based compensation expense recognized includes the compensation cost
for all share-based compensation payments granted to employees and nonemployees,
net of estimated forfeitures, over the employees requisite service period or the
non-employee performance period based on the grant date fair value estimated in
accordance with the provisions of ASC 718. ASC 718 is also applied to awards
modified, repurchased, or cancelled during the periods reported.



Recent accounting pronouncements


In February 2016, the Financial Accounting Standards Board ("FASB") issued new
leasing guidance ("Topic 842") that replaced the existing lease guidance ("Topic
840"). Topic 842 established a right-of-use ("ROU") model that requires a lessee
to record a ROU asset and lease liability on the balance sheet for all leases
with terms longer than 12 months. Leases are classified as either finance or
operating, with classification affecting the pattern of expense recognition in
the statement of operations. This guidance also expanded the requirements for
lessees to record leases embedded in other arrangements and the required
quantitative and qualitative disclosures surrounding leases.



The Company adopted Topic 842 on its effective date of January 1, 2019 using a
modified retrospective transition approach; as such, Topic 842 will not be
applied to periods prior to adoption and the adoption had no impact on the
Company's previously reported results. The Company elected the package of
practical expedients permitted under the transition guidance within Topic 842,
which allowed the Company to carry forward its identification of contracts that
are or contain leases, its historical lease classification and its accounting
for initial direct costs for existing leases. The impact of adopting Topic 842
was not material to the Company's result of operations or cash flows for the
three and nine months ended September 30, 2020 and 2019. The Company recognized
operating lease liabilities of approximately $350,000 upon adoption, with
corresponding ROU assets on its balance sheet on January 1, 2019.



Currency exchange rates



Our functional currency is the U.S. dollar, and the functional currency of our
operating subsidiaries and VIE is the RMB. All of our sales are denominated in
RMB. As a result, changes in the relative values of U.S. dollars and RMB affect
our reported levels of revenues and profitability as the results of our
operations are translated into U.S. dollars for reporting purposes. In
particular, fluctuations in currency exchange rates could have a significant
impact on our financial stability due to a mismatch among various foreign
currency-denominated sales and costs. Fluctuations in exchange rates between the
U.S. dollar and RMB affect our gross and net profit margins and could result in
foreign exchange and operating losses.



Our exposure to foreign exchange risk primarily relates to currency gains or
losses resulting from timing differences between signing of sales contracts and
settling of these contracts. Furthermore, we translate monetary assets and
liabilities denominated in other currencies into RMB, the functional currency of
our operating subsidiaries. Our results of operations and cash flow are
translated at average exchange rates during the period, and assets and
liabilities are translated at the unified exchange rate at the end of the
period. Translation adjustments resulting from this process are included in
accumulated other comprehensive income in our statement of shareholders' equity.
We have not used any forward contracts, currency options or borrowings to hedge
our exposure to foreign currency exchange risk. We cannot predict the impact of
future exchange rate fluctuations on our results of operations and may incur net
foreign currency losses in the future.



Our financial statements are expressed in U.S. dollars, which is the functional
currency of our parent company. The functional currency of our operating
subsidiaries and affiliates is RMB. To the extent we hold assets denominated in
U.S. dollars, any appreciation of the RMB against the U.S. dollar could result
in a charge in our statement of operations and a reduction in the value of our
U.S. dollar denominated assets. On the other hand, a decline in the value of RMB
against the U.S. dollar could reduce the U.S. dollar equivalent amounts of

our
financial results.



28






Results of Operations



The following tables set forth key components of our results of operations for
the periods indicated, in dollars. The discussion following the table is based
on these results:



                                    Three Months Ended                 Nine Months Ended
                                       September 30,                     September 30,
                                   2020             2019             2020             2019
Revenues - third parties       $    498,346     $    (16,652 )   $    679,844     $  9,799,286
Revenues - related parties        9,856,869          684,178       21,266,710       14,947,466
Total revenues                   10,355,215          667,526       21,946,554       24,746,752
Cost of revenues - third
parties                             463,359         (224,076 )        845,929        9,632,431
Cost of revenues - related
parties                           8,389,574          932,810       17,870,705       13,350,942
Total cost of revenues            8,829,857          708,734       18,693,558       22,983,373
Gross profit (loss)               1,525,358          (41,208 )      3,252,996        1,763,379
Operating expenses, net              31,180       (1,113,427 )        744,930         (990,315 )
Income from operations            1,494,178        1,072,219        2,508,066        2,753,694
Other (expenses) income            (471,052 )         70,481         (595,961 )        253,958
Net income before income
taxes                             1,023,126        1,142,700        1,912,105        3,007,652
(Provision) benefit for
income taxes                        (27,152 )         40,933          (27,152 )        (10,554 )
Net income                          995,974        1,183,633        1,884,953        2,997,098
Other comprehensive income
(loss):
Foreign currency translation
adjustment                        1,671,103       (1,651,817 )        957,348       (1,603,089 )
Comprehensive income (loss)    $  2,667,077     $   (468,184 )   $  2,842,301     $  1,394,009

Three and nine Months Ended September 30, 2020 Compared to Three and nine Months Ended September 30, 2019





Revenues



For the three months ended September 30, 2020, we had total revenues of
$10,355,215, as compared to $667,526 for the three months ended September 30,
2019, an increase of $9,687,689 or 1,451.28%. The increase in total revenue was
attributable to the increase in revenues of TCM raw materials and extracts.

For the nine months ended September 30, 2020, we had total revenues of $21,946,554, as compared to $24,746,752, for the nine months ended September 30, 2019, a decrease of $2,800,198 or 11.32%. The decrease in total revenue was attributable to the decrease in revenues of extracts, partially offset by increase in revenues of TCM raw materials.





29





Total revenue is summarized as follows:





                        Three Months Ended
                           September 30,             Increase       Percentage
                        2020            2019        (Decrease)        Change
TCM raw materials   $  6,844,205     $  766,763     $ 6,077,442          792.61 %
Handicrafts                9,599          1,049           8,550          815.06 %
Extracts               3,482,058       (192,601 )     3,674,659       (1,907.91 )
Others                    19,353         92,315         (72,962 )        (79.04 )%
Total               $ 10,355,215     $  667,526     $ 9,687,689        1,451.28 %




                          Nine Months Ended
                            September 30,               Increase        Percentage
                        2020             2019          (Decrease)         Change
TCM raw materials   $ 13,927,843     $  7,755,545     $  6,172,298            79.59 %
Handicrafts                9,599            7,167            2,432            33.93 %
Extracts               7,808,261       16,772,649       (8,964,388 )         (53.45 )
Others                   200,851          211,391          (10,540 )          (4.99 )%
Total               $ 21,946,554     $ 24,746,752     $ (2,800,198 )         (11.32 )%




For the three months ended September 30, 2020 compared to September 30, 2019,
the increase in extracts was mainly attributable to the increase in demand of
pine needle extract, complex taxus cuspidate extract, and composite northeast
yew extract. The increase in revenue of TCM raw material was mainly attributable
to the increase in demand from our related party, Yew Pharmaceutical.



For the nine months ended September 30, 2020 compared to September 30, 2019, the
decrease in extracts was mainly attributable to the decrease in demand of pine
needle extract, complex taxus cuspidate extract, and composite northeast yew
extract. The increase in revenue of TCM raw material was mainly attributable to
the increase in demand from our related party, Yew Pharmaceutical.



Cost of Revenues


For the three months ended September 30, 2020, cost of revenues amounted to $8,829,857 as compared to $708,734 for the three months ended September 30, 2019, an increase of $8,121,123 or 1,145.86%. For the three months ended September 30, 2020, cost of revenues accounted for 85.27% of total revenues compared to 106.17% of total revenues for the three months ended September 30, 2019.


For the nine months ended September 30, 2020, cost of revenues amounted to
$18,693,558 as compared to $22,983,373 for the nine months ended September 30,
2019, a decrease of $4,496,687 or 33.68%. For the nine months ended September
30, 2020, cost of revenues accounted for 85.17% of total revenues compared to
92.87% of total revenues for the nine months ended September 30, 2019.



Cost of revenues by product categories is as follows:





                        Three Months Ended
                           September 30,             Increase       Percentage
                       2020            2019         (Decrease)        Change
TCM raw materials   $ 5,255,828     $ 1,015,388     $ 4,240,440          417.62 %
Handicrafts               9,452           1,080           8,372          775.36 %
Extracts              3,647,661        (192,162 )     3,839,823       (1,998.22 )%
Others                  (83,084 )      (115,572 )        32,489          (28.11 )%
Total               $ 8,829,857     $   708,734     $ 8,121,123        1,145.86 %




30






                          Nine Months Ended
                            September 30,               Increase        Percentage
                        2020             2019          (Decrease)         Change
TCM raw materials   $ 10,825,135     $  6,159,705     $  4,665,430            75.74 %
Handicrafts                9,452            2,055            7,397           359.99 %
Extracts               7,497,537       16,734,324       (9,236,787 )         (55.20 )%
Others                   361,434           87,289          274,146           314.07 %
Total               $ 18,693,558     $ 22,983,373     $ (4,289,815 )         (18.66 )%



The increase and decrease in our cost of revenues for the three and nine months ended September 30, 2020 as compared to the three and nine months ended September 30, 2019 were in line with the increase in revenue.





Gross Profit



For the three months ended September 30, 2020, gross profit was $1,525,358 as
compared to $(41,208) for the three months ended September 30, 2019,
representing gross profit margins of 14.73% and (6.17) %, respectively. For the
nine months ended September 30, 2020, gross profit was $3,252,996 as compared to
$1,763,379 for the nine months ended September 30, 2019, representing gross
profit margins of 14.82% and 7.13%, respectively. Gross profit margins by
categories are as follows:



                                              Three Months Ended                           Nine Months Ended
                                                September 30,                                September 30,
                                                                (Decrease)                                  (Decrease)
                                     2020          2019          Increase          2020         2019         Increase
TCM raw materials                     23.21 %      (32.43 )%          55.64 %       22.28 %      20.58 %           1.70 %
Handicrafts                            1.54 %       (2.93 )%           4.47 %        1.54 %      71.33 %         (69.79 )%
Extracts                              (4.76 )%       0.23 %           (4.99 )%       3.98 %       0.23 %           3.75 %
Others                               529.32 %      225.19 %          304.13 %      (79.95 )%     58.71 %        (138.66 )%
Total                                 14.73 %       (6.17 )%          20.90 %       14.82 %       7.13 %           7.69 %




The increase in our overall gross profit margin for the three and nine months
ended September 30, 2020 as compared to the three and nine months ended
September 30, 2019 were primarily attributable to the increased sales percentage
of TCM raw materials and extracts which have higher gross margin.



Operating Expenses



For the three months ended September 30, 2020, operating expenses amounted to
$31,180, as compared to $(1,113,427) for the three months ended September 30,
2019, an increase of $1,144,608 or 102.80%. The increase was mainly due to the
decrease of bad debt recovery occurred during the three months ended September
30, 2020, as compared to that occurred during the three months ended September
30, 2019.



For the nine months ended September 30, 2020, operating expenses amounted to
$744,930 as compared to $(990,315) for the nine months ended September 30, 2019,
an increase of $1,735,245 or 175.22%. The increase was mainly due to the
decrease of bad debt recovery occurred during the nine months ended September
30, 2020, as compared to that occurred during the nine months ended September
30, 2019.



31






Income from Operations


For the three months ended September 30, 2020, income from operations was $1,494,178, as compared to income from operations of $1,072,219 for the three months ended September 30, 2019, an increase of $421,959, or 39.35%. The increase was primarily attributable to the increase in gross profit.





For the nine months ended September 30, 2020, income from operations was
$2,508,066, as compared to income from operations of $2,753,694 for the nine
months ended September 30, 2019, a decrease of $245,628 or 8.92%. The increase
was primarily attributable to the increase in gross profit after offset by the
decrease in bad debt recovery.



Other (Expense) Income



For the three months ended September 30, 2020, total other expense was $471,052
as compared to total other income of $70,481 for the three months ended
September 30, 2019. The decrease was primarily attributable to the decrease

of
exchange gain.



For the nine months ended September 30, 2020, total other expense was $595,961
as compared to total other income of $253,958 for the nine months ended
September 30, 2019. The decrease was primarily attributable to the decrease

of
exchange gain.



Net Income



As a result of the factors described above, our net income was $995,974 or $0.02
(basic and diluted), for the three months ended September 30, 2020, as compared
to net income of $1,183,633 or $0.02 (basic and diluted), for the three months
ended September 30, 2019. As a result of the factors described above, our net
income was $1,884,953 or $0.04 (basic and diluted), for the nine months ended
September 30, 2020, as compared to net income of $2,997,098 or $0.06 (basic and
diluted), for the nine months ended September 30, 2019.



Foreign Currency Translation Adjustment





For the three months ended September 30, 2020, we reported an unrealized gain on
foreign currency translation of $1,671,103, as compared to an unrealized loss of
$1,651,817 for the three months ended September 30, 2019. For the nine months
ended September 30, 2020, we reported an unrealized gain on foreign currency
translation of $957,348, as compared to an unrealized loss of $1,603,089 for the
nine months ended September 30, 2019. The change reflects the effect of the
value of the U.S. dollar in relation to the RMB. As described elsewhere herein,
the functional currency of our subsidiary, JSJ, and our VIE, HDS, is the RMB.
The accompanying consolidated financial statements have been translated and
presented in U.S. dollars using period end rates of exchange for assets and
liabilities, and average rates of exchange for the period for net revenues,
costs, and expenses. Net gains resulting from foreign exchange transactions, if
any, are included in the consolidated statements of income and comprehensive
income.



Comprehensive Income



For the three months ended September 30, 2020, comprehensive income of
$2,667,077 was derived from the sum of our net income of $995,974 with foreign
currency translation gain of $1,671,103. For the three months ended September
30, 2019, comprehensive loss of $468,184 was derived from the sum of our net
income of $1,183,633 with foreign currency translation loss of $1,651,817.



For the nine months ended September 30, 2020, comprehensive income of $2,842,301
was derived from the sum of our net income of $1,884,953 with foreign currency
translation gain of $957,348. For the nine months ended September 30, 2019,
comprehensive income of $1,394,009 was derived from the sum of our net income of
$2,997,098 with foreign currency translation loss of $1,603,089.



Segment Information



For the three and nine months ended September 30, 2020 as compared to the three
and nine months ended September 30, 2019, we operated in two reportable business
segments. The business of HDS, JSJ, HYF and JCB in PRC was managed and reviewed
as PRC segment. The business of YBP, Yew Bio-Pharm (HK), and MC was managed

and
reviewed as USA segment.



32





Information with respect to these reportable business segments for the three months ended September 30, 2020 and 2019 was as follows:





                                    For the three months                           For the three months
                                     September 30, 2020                             September 30, 2019
                         Revenues-      Revenues -                       Revenues-       Revenues -
                           third          related                          third          related
                          parties          party           Total          parties          party           Total
Revenues:
PRC                      $  481,661     $ 9,856,869     $ 10,338,530     $ (103,299 )   $    684,178     $ 580,879

USA                          16,685               -           16,685         86,647                -        86,647

Total revenues           $  498,346     $ 9,856,869     $ 10,355,215     $ 

(16,562 )   $    684,178     $ 667,526

Information with respect to these reportable business segments for the nine months ended September 30, 2020 and 2019 was as follows:





                                       For the six months                               For the six months
                                       September 30, 2020                               September 30, 2019
                          Revenues-       Revenues -                        Revenues-       Revenues -
                            third          related                            third          related
                           parties          party            Total           parties          party            Total
Revenues:
PRC                       $  641,316     $ 21,266,710     $ 21,908,026     $ 9,593,592     $ 14,947,466     $ 24,541,058

USA                           38,528                -           38,528         205,694                -          205,694

Total revenues            $  679,844     $ 21,266,710     $ 21,946,554     $ 9,799,286     $ 14,947,466     $ 24,746,752
During the three months ended September 30, 2020 and 2019, the revenue from PRC
segment was $10,338,530 and $580,879, respectively, increase of $9,757,651 or
1,679.81% due to the increase demand on Asia market. The increase in PRC segment
was mainly due to the increase in revenue from related parties in the amount of
$9,172,691, and the increase in revenue from third parties in the amount of
584,960.



During the three months ended September 30, 2020 and 2019, the revenue from USA
segment was $16,658 and $86,647, respectively, decrease of $69,962 or 80.74%.
The decrease in USA segment was due to the decrease in revenue from third
parties in the amount of $69,962 attributable to our China customers decreased
oversea demand.



During the nine months ended September 30, 2020 and 2019, the revenue from PRC
segment was $21,908,026 and $24,541,058, respectively, decrease of $2,633,032 or
10.73% due to the decrease demand on Asia market. The decrease in PRC segment
was mainly due to the decrease in revenue from third parties in the amount of
$8,952,276, offset by the increase in revenue from related parties in the amount
of 6,319,244.



During the nine months ended September 30, 2020 and 2019, the revenue from USA
segment was $38,528 and $205,694, respectively, decrease of $167,166 or 81.27%.
The decrease in USA segment was due to the decrease in revenue from third
parties in the amount of $167,166 attributable to our China customers decreased
oversea demand.



33





Liquidity and Capital Resources





Liquidity is the ability of a company to generate funds to support its current
and future operations, satisfy its obligations and otherwise operate on an
ongoing basis. On September 30, 2020 and December 31, 2019, we had cash balances
of $1,224,293 and $742,294, respectively. These funds are primarily located in
various financial institutions located in China. Our primary uses of cash have
been for the purchase of yew trees, land use rights and yew forest assets.
Additionally, we use cash for employee compensation and working capital.



The following table sets forth information as to the principal changes in the
components of our working capital from December 31, 2019 to September 30, 2020:



                                September 30,      December 31,                        Percentage
Category                            2020               2019             Change           change
      Current assets:
Cash                           $     1,224,293     $     742,294     $    481,999            64.93 %
Accounts receivable                  2,180,937         7,692,613       (5,511,676 )         (71.65 )%
Accounts receivable -
related parties, net                 7,113,073           198,829        6,914,244         3,477.48 %
Inventories, net                     2,648,954         2,637,389           11,565             0.44 %
Prepaid expenses and other
assets                                  88,215            51,140           37,075            72.50 %
VAT recoverable                        367,083           349,096           17,987             5.15 %
    Current liabilities:
Accounts payable for
acquisition of yew forests
and others                             678,519           920,459         (241,940 )         (26.28 )%
Accounts payable for
acquisition of yew forests
and others - related parties           103,363            16,629          

86,734           521.58 %
Advances from customers                182,534            50,071          132,463           264.55 %
Accrued expenses and other
payables                               344,516           266,749           77,767            29.15 %
Due to related parties                 660,756           633,779           26,977             4.26 %
Short-term borrowings                8,166,609         8,541,517         (374,908 )          (4.39 )%
Operating lease liabilities,
current                                 61,773            52,104            9,669            18.56 %
Working capital:
Total current assets           $    13,596,960     $  11,671,361     $  1,925,599            16.50 %
Total current liabilities           10,198,070        10,481,308         (283,238 )          (2.70 )%
Working capital                $     3,398,890     $   1,190,053     $  2,208,837           185.61 %




34





Our working capital increased by $2,208,837 to $3,398,890 on September 30, 2020, from working capital of $1,190,053 on December 31, 2019. This increase in working capital is primarily attributable to:





  ? an increase in accounts receivable - related parties of approximately
    $6,900,000
  ? an increase in cash of approximately $480,000
  ? a decrease in short-term borrowings of approximately $380,000




partially offset by:



? a decrease in accounts receivable of approximately $5,500,000

? a decrease in accounts payable for acquisition of yew forests and others of


    approximately $240,000




For the nine months ended September 30, 2020, net cash flow provided by
operating activities was $12,210,618, as compared to net cash flow provided by
operating activities of $11,541,211 for the nine months ended September 30,
2019, an increase of $669,406. Because the exchange rate conversion is different
for the balance sheet and the statements of cash flows, the changes in assets
and liabilities reflected on the statements of cash flows are not necessarily
identical with the comparable changes reflected on the balance sheets.



For the nine months ended September 30, 2020, net cash flow provided by operating activities was $12,210,618 was primarily attributable to:

? net income of approximately $1,880,000 adjusted for the add-back of non-cash


    items, such as sale of yew forest assets as inventory of approximately
    8,800,000 and amortization of land use rights and yew forest assets of
    approximately $2,000,000; and

? Changes in operating assets and liabilities, such as a decrease in accounts


    receivable of approximately $5,600,000, and an increase in accounts
    receivable-related parties of approximately $6,900,000.




35

For the nine months ended September 30, 2019, net cash flow provided by operating activities of $11,541,211 was primarily attributable to:

? net income of approximately $2,997,000 adjusted for the add-back of non-cash

items, such as sale of yew forest assets as inventory of approximately

4,788,000, amortization of land use rights and yew forest assets of

approximately $1,449,000, and bad debt recovery of approximately $1,896,000;

and

? Changes in operating assets and liabilities, such as an increase in accounts


    receivable of approximately $7,983,000, a decrease in accounts
    receivable-related parties of approximately $4,197,000, a decrease in
    inventories of approximately $5,881,000, and an increase in accounts
    payable-related party of approximately $1,268,000.




Net cash flow used in investing activities was approximately $11,000,000 for the
nine months ended September 30, 2020. During the nine months ended September 30,
2020, we have made payment in approximately $11,000,000 for purchase of yew
forest assets and made payment for purchase of property and equipment $150,000.
Net cash flow used in investing activities was approximately $14,000,000 for the
nine months ended September 30, 2019. During the nine months ended September 30,
2019, we have made payment in approximately $14,000,000 for purchase of yew
forest assets, and in approximately $19,000 for purchase of property and
equipment.



Net cash flow provided by financing activities was approximately $500,000 for
the nine months ended September 30, 2020 and consisted of proceeds of
$10,920,000 from banks and offset by repayments of approximately $10,420,000.
Net cash flow provided by financing activities was approximately $2,519,000 for
the nine months ended September 30, 2019 and consisted of proceeds of
$10,543,000 from banks and offset by repayments of approximately $8,045,000.



We have historically financed our operations and capital expenditures through
cash flows from operations, bank loans and advances from related parties. From
March 2008 to September 2009, we received approximately $2.9 million of proceeds
in the aggregate from offerings and sales of our common stock. Except for the
portion used to pay for professional and other expenses in the U.S., substantial
portions of the proceeds we received through sales of our common stock were
retained in the PRC and used to fund our working capital requirements. As the
PRC government imposes controls on PRC companies' ability to convert RMB into
foreign currencies and the remittance of currency out of China, from time to
time, in order to fund our corporate activities in the U.S., Zhiguo Wang, our
President and CEO, advanced funds to us in the U.S. and we repaid the amounts
owed to him in RMB in the PRC.



It is management's intention to expand our operations as quickly as reasonably
practicable to capitalize on the demand opportunity for our products. We
regularly review our cash funding requirements and attempt to meet those
requirements through a combination of cash on hand, cash provided by operations
and any potential available bank borrowings. We believe that we can continue
meeting our cash funding requirements for our business in this manner over at
least the next twelve months. The majority of our funds are maintained in RMB in
bank accounts in China. We receive most of our revenue in the PRC. Under
existing PRC foreign exchange regulations, payments of current account items,
including profit distributions, interest payments and expenditures from trade
related transactions, can be made in foreign currencies by complying with
certain procedural requirements. However, approval from China's State
Administration of Foreign Exchange ("SAFE") or its local counterparts is
required where RMB is to be converted into foreign currency and remitted out of
China to pay capital expenses such as the repayment of loans denominated in
foreign currencies. The PRC government may also, at its discretion, restrict
access to foreign currencies for current account transactions. As of September
30, 2020, and December 31, 2019, approximately $48.4 million and $44.6 million,
respectively, of our net assets are located in the PRC. If the foreign exchange
control system in the PRC prevents us from obtaining sufficient foreign currency
to satisfy our currency demands, we may not be able to transfer funds deposited
within the PRC to fund working capital requirements in the U.S. or pay any
dividends in currencies other than the RMB, to our shareholders.



Off-Balance Sheet Arrangements





We have not entered into any financial guarantees or other commitments to
guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to our shares and classified as
shareholder's equity or that are not reflected in our consolidated financial
statements. Furthermore, we do not have any retained or contingent interest in
assets transferred to an unconsolidated entity that serves as credit, liquidity
or market risk support to such entity. We do not have any variable interest in
any unconsolidated entity that provides financing, liquidity, market risk or
credit support to us or engages in leasing, hedging or research and development
services with us.



36

© Edgar Online, source Glimpses